Diagnostic intervals and its association with breast, prostate, lung and colorectal cancer survival in England: Historical cohort study using the Clinical Practice Research Datalink

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Redaniel, Maria Theresa ^a   Martin, Richard M ^a   Ridd, Matthew J ^a   Wade, Julia ^a   Jeffreys, Mona ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANXIETY; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL PRACTICE; COHORT ANALYSIS; COLORECTAL CANCER; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; SYMPTOM; UNITED KINGDOM; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; DATA BASE; DEMOGRAPHY; ENGLAND; EPIDEMIOLOGY; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; COHORT STUDIES; COLORECTAL NEOPLASMS; DATABASES AS TOPIC; DEMOGRAPHY; ENGLAND; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84928803026     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126608     Document Type: Article

References (60)

1. Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2011. 377: 127-138. doi: 10.1016/S0140-6736(10)62231-3 PMID: 21183212
2. Holmberg L, Robinson D, Sandin F, Bray F, Linklater KM, Klint A, et al. A comparison of prostate cancer survival in England, Norway and Sweden: a population-based study. Cancer Epidemiol. 2012. 36: e7-12. doi: 10.1016/j.canep.2011.08.001 PMID: 21907655
3. De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol. 2014. 15: 23-34. doi: 10.1016/S1470-2045(13)70546-1 PMID: 24314615
4. Richards MA. The size of the prize for earlier diagnosis of cancer in England. Br J Cancer. 2009. 101 Suppl 2: S125-129. doi: 10.1038/sj.bjc.6605402 PMID: 19956156
5. Department of Health. The NHS Cancer Plan. London: Department of Health. 2000.
6. Department of Health. Cancer Reform Strategy. London: Department of Health. 2007.
7. National Institute for Health and Clinical Excellence. Referral guidelines for suspected cancer. London: National Institute for Health and Clinical Excellence. 2005.
8. National Institute for Health and Clinical Excellence. Referral guidelines for suspected cancer. 2014. [cited March 13, 2015]. Available: https://www.nice.org.uk/guidance/cg27.
9. Neal RD, Allgar VL. Sociodemographic factors and delays in the diagnosis of six cancers: analysis of data from the "National Survey of NHS Patients: Cancer". Br J Cancer. 2005. 92: 1971-1975. PMID: 15900296
10. Department of Health, Public Health England, NHS England. Improving outcomes: a strategy for cancer- third annual report. London: Department of Health.2013; pp.
11. Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer. 1999. 79: 858-864. PMID: 10070881
12. Torring ML, Frydenberg M, Hamilton W, Hansen RP, Lautrup MD, Vedsted P. Diagnostic interval and mortality in colorectal cancer: U-shaped association demonstrated for three different datasets. J Clin Epidemiol. 2012. 65: 669-678. doi: 10.1016/j.jclinepi.2011.12.006 PMID: 22459430
13. Porta M, Gallen M, Malats N, Planas J. Influence of "diagnostic delay" upon cancer survival: an analysis of five tumour sites. J Epidemiol Community Health. 1991. 45: 225-230. PMID: 1757766
14. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999. 353: 1119-1126. PMID: 10209974
15. Ramos M, Esteva M, Cabeza E, Campillo C, Llobera J, Aguilo A. Relationship of diagnostic and therapeutic delay with survival in colorectal cancer: a review. Eur J Cancer. 2007. 43: 2467-2478. PMID: 17931854
16. Dregan A, Møller H, Charlton J, Gulliford M. Are alarm symptoms predictive of cancer survival? Br J Gen Pract.2013; 63: e807-812. doi: 10.3399/bjgp13X675197 PMID: 24351496
17. Rupassara KS, Ponnusamy S, Withanage N, Milewski PJ. A paradox explained? Patients with delayed diagnosis of symptomatic colorectal cancer have good prognosis. Colorectal Dis. 2006. 8: 423-429. PMID: 16684087
18. Terhaar sive Droste JS, Oort FA, van der Hulst RW, Coupe VM, Craanen ME, Meijer GA, et al. Does delay in diagnosing colorectal cancer in symptomatic patients affect tumor stage and survival? A population-based observational study. BMC Cancer. 2010. 10: 332. doi: 10.1186/1471-2407-10-332 PMID: 20584274
19. Gonzalez-Barcala FJ, Garcia-Prim JM, Alvarez-Dobano JM, Moldes-Rodriguez M, Garcia-Sanz MT, Pose-Reino A, et al. Effect of delays on survival in patients with lung cancer. Clin Transl Oncol. 2010. 12: 836-842. doi: 10.1007/s12094-010-0606-5 PMID: 21156415
20. Radzikowska E, Roszkowski-Sliz K, Chabowski M, Glaz P. Influence of delays in diagnosis and treatment on survival in small cell lung cancer patients. Adv Exp Med Biol. 2013. 788: 355-362. doi: 10.1007/978-94-007-6627-3-48 PMID: 23835998
21. Torring ML, Frydenberg M, Hansen RP, Olesen F, Vedsted P. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: A cohort study in primary care. Eur J Cancer. 2013.
22. Pruitt SL, Harzke AJ, Davidson NO, Schootman M. Do diagnostic and treatment delays for colorectal cancer increase risk of death? Cancer Causes Control. 2013. 24: 961-977. doi: 10.1007/s10552-013-0172-6 PMID: 23446843
23. Neal RD, Tharmanathan P, France B, Din NU, Cotton S, Fallon-Ferguson J, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015.
24. Neal RD. Do diagnostic delays in cancer matter? Br J Cancer. 2009. 101 Suppl 2: S9-S12. doi: 10.1038/sj.bjc.6605384 PMID: 19956171
25. Dregan A, Moller H, Murray-Thomas T, Gulliford MC. Validity of cancer diagnosis in a primary care database compared with linked cancer registrations in England. Population-based cohort study. Cancer Epidemiol. 2012.
26. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol. 2010. 69: 4-14. doi: 10.1111/j.1365-2125.2009.03537.x PMID: 20078607
27. Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract. 2010. 60: e128-136. doi: 10.3399/bjgp10X483562 PMID: 20202356
28. Kaye JA, Derby LE, del Mar Melero-Montes M, Quinn M, Jick H. The incidence of breast cancer in the General Practice Research Database compared with national cancer registration data. Br J Cancer. 2000. 83: 1556-1558. PMID: 11076668
29. CPRD. Cancer Registry data and CPRD. London: Clinical Practice Research Datalink. 2012.
30. Noble M, mcLennan D, Wilkinson K, Whitworth A, Barnes H, Dibben C. The English Indices of Deprivation 2007. London: Communities and Local Government. 2008.
31. Hamilton W. The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients. Br J Cancer. 2009. 101 Suppl 2: S80-86. doi: 10.1038/sj.bjc.6605396 PMID: 19956169
32. European Network of Cancer Registries. ENCR Definitions for the coding of basis of diagnosis. Lyon, France: ENCR. 1997.
33. Weller D, Vedsted P, Rubin G, Walter FM, Emery J, Scott S, et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer. 2012. 106: 1262-1267. doi: 10.1038/bjc.2012.68 PMID: 22415239
34. Department of Health. A Practical Guide to Ethnic Monitoring in the NHS and Social Care. London: Department of Health. 2005.
35. Hospital Episode Statistics. How good is HES ethnic coding and where do the problems lie? London: The Health and Social Care Information Centre. 2009.
36. Office of the Deputy Prime Minister. The English Indices of Deprivation 2004: Summary. London: Office of the Deputy Prime Minister. 2004.
37. Tavassoli F, Devilee P, editors. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC; 2003.
38. Bosman F, Carneiro F, Hruban R, Theise N, editors. Pathology and Genetics. Tumours of the Digestive System: IARC; 2010.
39. Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC, editors. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC; 2004.
40. Eble J, Sauter G, Epstein J, Sesterhenn I, editors. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC; 2004.
41. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987. 40: 373-383. PMID: 3558716
42. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr. 1961. 6: 101-121. PMID: 13889176
43. Brenner H, Gefeller O, Hakulinen T. Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation, computational realisation and applications. Eur J Cancer. 2004. 40: 326-335. PMID: 14746849
44. Cancer Research UK Cancer Survival Group. Life tables for England by sex, calendar period, region and deprivation. London School of Hygiene & Tropical Medicine.2009; pp.
45. Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med. 2004. 23: 51-64. PMID: 14695639
46. Nur U, Shack LG, Rachet B, Carpenter JR, Coleman MP. Modelling relative survival in the presence of incomplete data: a tutorial. Int J Epidemiol. 2010. 39: 118-128. doi: 10.1093/ije/dyp309 PMID: 19858106
47. Royston P. Multiple imputation of missing values: Update of ice The Stata Journal 2005. 5: 527-536.
48. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009. 338: b2393. doi: 10.1136/bmj.b2393 PMID: 19564179
49. StataCorp. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP.2011; pp.
50. Office of National Statistics. Cancer Registrations Statistics, England, 2011. 2013. [cited 19 September, 2014]. Available: http://www.ons.gov.uk/ons/rel/vsob1/cancer-statistics-registrations-england-series-mb1-/no-42-2011/stb-cancer-statistics-registrations-2011.html#tab-Cancer-registrations-interpretation-and-data-quality.
51. Myrdal G, Lambe M, Hillerdal G, Lamberg K, Agustsson T, Stahle E. Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax. 2004. 59: 45-49. PMID: 14694247
52. Salisbury C, Procter S, Stewart K, Bowen L, Purdy S, Ridd M, et al. The content of general practice consultations: cross-sectional study based on video recordings. Br J Gen Pract. 2013. 63: e751-759. doi: 10.3399/bjgp13X674431 PMID: 24267858
53. Neal RD, Din NU, Hamilton W, Ukoumunne OC, Carter B, Stapley S, et al. Comparison of cancer diagnostic intervals before and after implementation of NICE guidelines: analysis of data from the UK General Practice Research Database. Br J Cancer. 2014. 110: 584-592. doi: 10.1038/bjc.2013.791 PMID: 24366304
54. Rai S, Kelly MJ. Prioritization of colorectal referrals: a review of the 2-week wait referral system. Colorectal Dis. 2007. 9: 195-202. PMID: 17298615
55. Murchie P, Raja EA, Brewster DH, Campbell NC, Ritchie LD, Robertson R, et al. Time from first presentation in primary care to treatment of symptomatic colorectal cancer: effect on disease stage and survival. Br J Cancer. 2014. 111: 461-469. doi: 10.1038/bjc.2014.352 PMID: 24992583
56. OS M. Theoretical epidemiology: principles of occurence research in medicine. Ney York: John Wiley & Sons; 1985.
57. Hamilton W. Cancer diagnosis in primary care. Br J Gen Pract. 2010. 60: 121-128. doi: 10.3399/bjgp10X483175 PMID: 20132704
58. Korsgaard M, Pedersen L, Sorensen HT, Laurberg S. Reported symptoms, diagnostic delay and stage of colorectal cancer: a population-based study in Denmark. Colorectal Dis. 2006. 8: 688-695. PMID: 16970580
59. Williams JG, Roberts SE, Ali MF, Cheung WY, Cohen DR, Demery G, et al. Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence. Gut. 2007. 56 Suppl 1: 1-113. PMID: 17303614
60. Redaniel MT, Martin RM, Blazeby JM, Wade J, Jeffreys M. The association of time between diagnosis and major resection with poorer colorectal cancer survival: a retrospective cohort study. BMC Cancer. 2014. 14: 642. doi: 10.1186/1471-2407-14-642 PMID: 25175937